By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Science Briefing

Medicine

Science Briefing

Last updated: June 19, 2026 7:04 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE
[SUBJECT] GRM Network Disruptions Drive ADHD Comorbid Neurodevelopmental Profiles

Key Highlights

Medicine · Neurology

A large-scale genomic study has identified a distinct genetic signature in children with ADHD who also present with comorbid neurodevelopmental disorders (NDDs) such as autism spectrum disorder and anxiety. By analyzing copy number variant (CNV) data from over 72,000 pediatric participants, researchers found significant enrichment of CNVs within glutamatergic signaling networks involving genes that interact with metabotropic glutamate receptors (GRMs). This work reveals that disruptions in GRM-interacting pathways, including key synaptic genes like DLG2, NRXN1, SHANK3, and SYNGAP1, are specifically associated with the more complex clinical profiles seen in comorbid ADHD, offering a potential avenue for genetically informed interventions.

Novelty: 88%

Rigor: 92%

Significance: 85%

Validity: 90%

Clarity: 87%


Read the paper →



Update Your Briefing Preferences

Stay curious. Stay informed —

Science Briefing

Your briefing is personalized based on your selected fields, keywords, and research interests.

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Renewable Energy Science Briefing | June 19th 2026, 9:00:16 am
Next Article Science Briefing
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Today’s Neurology Science Briefing | March 13th 2026, 1:00:51 pm

A new frontier in diabetic complications: the brain-gut-microbiome axis

A Nationwide Blueprint: Improving Pregnancy Outcomes in Autoimmune Surgery Patients

Mapping the Early Brain: How Amyloid and Myelin Interact in Preclinical Alzheimer’s Disease

Science Briefing

Today’s Public Health Science Briefing | April 24th 2026, 9:00:12 am

Science Briefing

Vitamin D: A Dietary Defense Against Multiple Sclerosis?

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Uncategorized
  • Chemistry
  • Natural Language Processing
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?